Qingyu Yang

2.3k total citations · 1 hit paper
43 papers, 949 citations indexed

About

Qingyu Yang is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Qingyu Yang has authored 43 papers receiving a total of 949 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Qingyu Yang's work include Viral Infections and Immunology Research (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and COVID-19 Clinical Research Studies (7 papers). Qingyu Yang is often cited by papers focused on Viral Infections and Immunology Research (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and COVID-19 Clinical Research Studies (7 papers). Qingyu Yang collaborates with scholars based in China, United States and France. Qingyu Yang's co-authors include You Shang, Yaxin Wang, Xiaobo Yang, Jiqian Xu, Yongran Wu, Yu Yuan, Ziwen Yang, Liqiao Shi, Jianguo Wu and Shaoyong Ke and has published in prestigious journals such as Journal of Virology, Scientific Reports and The FASEB Journal.

In The Last Decade

Qingyu Yang

35 papers receiving 929 citations

Hit Papers

Thrombocytopenia and its association with mortality in pa... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingyu Yang China 15 433 244 167 164 162 43 949
Xuemei Jiang China 19 239 0.6× 435 1.8× 156 0.9× 87 0.5× 52 0.3× 66 1.0k
Mizuki Yamamoto Japan 16 466 1.1× 473 1.9× 83 0.5× 209 1.3× 86 0.5× 42 1.1k
Klaus G. Schmetterer Austria 24 117 0.3× 399 1.6× 162 1.0× 337 2.1× 64 0.4× 66 1.7k
Natalie J. Carter New Zealand 17 152 0.4× 198 0.8× 220 1.3× 130 0.8× 35 0.2× 32 993
Kangtai Liu China 6 636 1.5× 262 1.1× 137 0.8× 60 0.4× 144 0.9× 8 1.1k
Luca Braga Italy 18 879 2.0× 993 4.1× 175 1.0× 117 0.7× 177 1.1× 35 2.3k
Jinxiu Li China 10 1.0k 2.4× 501 2.1× 149 0.9× 144 0.9× 484 3.0× 21 1.9k
Yuanhong Zhou China 11 271 0.6× 295 1.2× 221 1.3× 128 0.8× 120 0.7× 23 1.0k
Izidor Kern Slovenia 18 176 0.4× 248 1.0× 161 1.0× 360 2.2× 109 0.7× 62 1.2k
Lillian Zalduondo United States 7 409 0.9× 539 2.2× 172 1.0× 97 0.6× 154 1.0× 9 1.2k

Countries citing papers authored by Qingyu Yang

Since Specialization
Citations

This map shows the geographic impact of Qingyu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingyu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingyu Yang more than expected).

Fields of papers citing papers by Qingyu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingyu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingyu Yang. The network helps show where Qingyu Yang may publish in the future.

Co-authorship network of co-authors of Qingyu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingyu Yang. A scholar is included among the top collaborators of Qingyu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingyu Yang. Qingyu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Qingyu, et al.. (2025). Voxtalisib inhibits enterovirus 71 replication by downregulating host RAN and restoring IFN–STAT signaling. Journal of Advanced Research. 81. 569–582. 1 indexed citations
2.
Wang, Xijie, et al.. (2025). Accelerating or Slowing: Fine Tuning the De‐Threading Kinetics of a T‐Shaped Benzimidazolium Pumping Cassette. Chemistry - A European Journal. 31(39). e202501605–e202501605.
4.
Sun, Chuqing, Liwen Yi, Wei Ge, et al.. (2024). Integrated analysis of facial microbiome and skin physio-optical properties unveils cutotype-dependent aging effects. Microbiome. 12(1). 163–163. 6 indexed citations
5.
Huang, Ze, Zongyan Li, Xiaofang Zhong, et al.. (2024). Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction. Journal of Visualized Experiments. 3 indexed citations
6.
Yang, Qingyu, et al.. (2023). PLX8394, a RAF inhibitor, inhibits enterovirus 71 replication by blocking RAF/MEK/ERK signaling. Virologica Sinica. 38(2). 276–284. 5 indexed citations
7.
Wang, Qian, et al.. (2023). Antiviral activity of the HSP90 inhibitor VER-50589 against enterovirus 71. Antiviral Research. 211. 105553–105553. 6 indexed citations
8.
Yang, Qingyu. (2023). Existing and Potential Causes of Perfectionism. Communications in Humanities Research. 18(1). 1–7.
9.
Yang, Qingyu, Xujuan Hu, Ke Peng, et al.. (2022). ML390 inhibits enterovirus 71 replication by targeting de novo pyrimidine biosynthesis pathway. Antiviral Research. 209. 105498–105498. 5 indexed citations
10.
Yang, Jingyi, Maohua Zhong, Ejuan Zhang, et al.. (2021). Broad phenotypic alterations and potential dysfunction of lymphocytes in individuals clinically recovered from COVID-19. Journal of Molecular Cell Biology. 13(3). 197–209. 21 indexed citations
11.
Zhong, Maohua, Qingyu Yang, Ke Hong, et al.. (2021). Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study. Virologica Sinica. 36(5). 859–868. 14 indexed citations
12.
Han, Yang, Peipei Liu, Yang Qiu, et al.. (2021). Effective virus-neutralizing activities in antisera from the first wave of severe COVID-19 survivors. JCI Insight. 6(4). 9 indexed citations
13.
Li, Shihua, Wei Yang, Xuancheng Lu, et al.. (2020). Matrix metalloproteinase 9 facilitates Zika virus invasion of the testis by modulating the integrity of the blood-testis barrier. PLoS Pathogens. 16(4). e1008509–e1008509. 50 indexed citations
14.
Yang, Hua, Weiyong Liu, Jian Shang, et al.. (2020). SOX9 represses hepatitis B virus replication through binding to HBV EnhII/Cp and inhibiting the promoter activity. Antiviral Research. 177. 104761–104761. 12 indexed citations
15.
Han, Yang, Qingyu Yang, Ying Liu, et al.. (2020). Feasibility Study of Mixing Throat Swab Samples for Severe Acute Respiratory Syndrome Coronavirus-2 Screening. Virologica Sinica. 35(6). 830–832. 5 indexed citations
16.
Wan, Pin, Qí Zhāng, Weiyong Liu, et al.. (2019). Cullin1 binds and promotes NLRP3 ubiquitination to repress systematic inflammasome activation. The FASEB Journal. 33(4). 5793–5807. 59 indexed citations
17.
Wang, Zili, Qingyu Yang, Fangyu Zhao, et al.. (2018). Diosgenin Glucoside Protects against Spinal Cord Injury by Regulating Autophagy and Alleviating Apoptosis. International Journal of Molecular Sciences. 19(8). 2274–2274. 39 indexed citations
18.
Yang, Qingyu, Qing Mao, Manli Liu, et al.. (2016). The inhibitory effect of dehydroepiandrosterone and its derivatives against influenza A virus in vitro and in vivo. Archives of Virology. 161(11). 3061–3072. 16 indexed citations
19.
Zhang, Qi, Wei Liang, Wanqi Yang, et al.. (2015). Bromodomain containing protein represses the Ras/Raf/MEK/ERK pathway to attenuate human hepatoma cell proliferation during HCV infection. Cancer Letters. 371(1). 107–116. 31 indexed citations
20.
Ke, Shaoyong, Yanhong Wei, Liqiao Shi, Qingyu Yang, & Ziwen Yang. (2013). Synthesis of Novel Steroid Derivatives Derived from Dehydroepiandrosterone as Potential Anticancer Agents. Anti-Cancer Agents in Medicinal Chemistry. 13(8). 1291–1298. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026